Caveolae and the caveolins in human disease

Advanced Drug Delivery Reviews

Volumn 49, Issue 3, 2001, Pages 325-335

  Campbell, Lee ^a   Gumbleton, Mark ^a   Ritchie, Kenneth ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Alzheimer's disease; Atherosclerosis; Cancer; Caveolae; Caveolin; Diabetes; Disease; Inflammation; Muscular dystrophy

Indexed keywords

BIOLOGICAL MEMBRANES; DISEASES; LIPIDS; PATHOLOGY; PROTEINS;

PEPTIDES;

PHARMACODYNAMICS;

AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; CAVEOLIN 1; CAVEOLIN 3; DYSTROPHIN; GAMMA SECRETASE; GLUCOSE TRANSPORTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN TYROSINE KINASE; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; ATHEROGENESIS; ATHEROSCLEROSIS; CANCER; CARCINOGENESIS; CAVEOLA; CELL COMPARTMENTALIZATION; CELL FUNCTION; DUCHENNE MUSCULAR DYSTROPHY; ENZYME ACTIVATION; HUMAN; HYPERCHOLESTEROLEMIA; INFLAMMATION; MEMBRANE STRUCTURE; MEMBRANE VESICLE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

CAVEOLAE; CAVEOLINS; DISEASE; HUMANS;

EID: 0035963959     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(01)00145-4     Document Type: Review

References (67)

1. Blood capillaries of the heart and other organs
2. Molecular genetics of the caveolin gene family: Implications for human cancers, diabetes, Alzheimer disease, and muscular dystrophy
3. Caveolins in cholesterol trafficking and signal transduction: Implications for human disease
4. Dystrophin: The protein product of the Duchenne muscular dystrophy
5. Freeze-fracture studies of muscle caveolae in human muscular dystrophy
6. Molecular cloning of caveolin-3 gene family expressed predominantly in muscle
7. Expression of caveolin-3 in skeletal muscle, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins
8. Caveolin-3 directly interacts with the C-terminal tail of beta-dystroglycan
9. Increased number of caveolae and caveolin-3 in Duchenne muscular dystrophy
10. Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype
11. Increased caveolin-3 in mdx mouse muscles
12. DNA-fragmentation and expression of apoptosis-related proteins in muscular dystrophies
13. The 1999 Mayor award. Burn injury induces skeletal muscle apoptosis and the caspase pathways in rats
14. Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy
15. Caveolin-3 in muscular dystrophy
16. Localisation of the human caveolin-3 gene to the D3S18/D3S4163/D3S4539 locus (3p25) in close proximity to the human oxytocin receptor gene. Identification of the caveolin-3 gene as a candidate for deletion in 3p-syndrome
17. Phenotypic behaviour of caveolin-3 mutants that cause autosomal limb girdle muscular dystrophy (LGMD-1C). Retention of LGMD-1C caveolin-3 mutants within the golgi complex
18. Limb-girdle muscular dystrophy (LGMD) mutants of caveolin-3 undergo ubiquitination and proteasomal degradation
19. Interaction of neuronal nitric-oxide synthase with caveolin-3 in skeletal muscle. Identification of a novel caveolin scaffolding/inhibitory domain
20. Expression of naked plasmids by cultured myotubes and entry of plasmids into T tubules and caveolae of mammalian skeletal muscle
21. Cyclins, cyclin dependent kinases and differentiation
22. Visualisation of caveolin-1, a caveolar marker protein, in living cells using green flourescent protein (GFP) chimeras
23. Reduction of caveolin and caveolae in oncogenically transformed cells
24. Chromosomal localisation, genomic organisation, and developmental expression of the murine caveolin gene family (Cav-1, -2, and -3)
25. Genes encoding human caveolin-1 and 2 are co-localised to the D7S522 locus (7q31.1) a known fragile site (FRA7G) that is frequently deleted in human human cancers
26. Sequence and detailed organisation of the human caveolin-1 and -2 genes located near the D7S522 locus (7q31.1)
27. Human caveolin-1 and caveolin-2 are closely linked genes colocalized with WI-5336 in a region of 7q31 frequently deleted in tumors
28. Analysis of the caveolin-1 gene at human chromosome 7q31.1 in primary tumours and tumour-derived cell lines
29. Reduction of caveolin gene expression in lung carcinoma cell lines
30. Reduction of caveolin-1 in Tumorigenic human cell hybrids
31. Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells
32. Targetted down regulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade
33. Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in-vivo
34. Reciprocal regulation of neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo. Implications for human breast cancer
35. DNA methylation as a target for drug design
36. Sequence and detailed organisation of the human caveolin-1 and -2 genes located near the D7S522 locus (7q31.1). Methylation of a CpG island in the 5′promoter region of the caveolin-1 gene in human breast cancer cell lines
37. Caveolin-1 expression in clinically confined human prostate cancer: A novel prognostic marker
38. Elevated caveolin-1 levels in African-American versus white-american prostate cancer
39. Suppression of caveolin expression induces androgen sensitivity in metastatic androgen insensitive mouse prostate cancer cell lines
40. Caveolin-1 is regulated by c-myc and suppresses c-myc-induced apoptosis
41. Impaired glucose transport as a cause of decreased insulin-stimulated muscle-glycogen synthesis in type 2 diabetes
42. Immuno-localisation of the insulin regulatable glucose transporter in brown adipose tissue of the rat lung
43. Insulin and alpha-2-macroglobulin undergo endocytosis by different mechanisms in rat adipocytes
44. Induction of caveolin during adipogenesis and association of GLUT4 with caveolin-rich vesicles
45. Insulin stimulated glucose uptake involves the transition of glucose transporters to a caveolae-rich fraction within the plasma membrane: Implications for type II diabetes
46. Expression of insulin-regulated distribution of caveolin in skeletal muscle
47. Antioxidants, diabetes and endothelial dysfunction
48. Caveolin proteins in signalling, oncogenic transformation and muscular dystrophy
49. A mutation (Trp1193-Leu1193) in the tyrosine kinase domain of the insulin receptor associated with type A syndrome of insulin resistance
50. Tumour necrosis factor α-mediated insulin resistance, but not dedifferentiation, is abrogated by MEK1/2 inhibitors in 3T3-L1 adipocytes
51. Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes
52. The molecular mechanism of the insulin-mimetic/senitising activity of the antidiabetic sulfonylurea drug Amaryl
53. 2+-calmodulin and caveolin
54. Caveolin versus calmodulin: Counterbalancing allosteric modulators of endothelial nitric oxide synthase
55. Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase
56. Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance
57. Hypercholesterolemia increases endothelial superoxide anion production
58. Opposing effects of reactive oxygen species and cholesterol on nitric oxide synthase and endothelial cell caveolae
59. Oxygen-derived free radicles, endothelium and responsiveness of vascular smooth muscle
60. In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation
61. Trojan peptides: The penetration system for intracellular delivery
62. Axonal amyloid precursor protein expressed by neurons in vitro is present in a membrane fraction with caveolae-like properties
63. o heterotrimeric protein within a cell compartment specialised in signal transduction
64. Cholesterol depletion inhibits the generation of β-amyloid in hippocampal neurons
65. Caveolae, plasma membrane microdomains for □-secretase-mediated processing of the amyloid precursor protein
66. Caveolin-3 upregulation activates β-secretase-mediated cleavage of the amyloid precursor protein in Alzheimers disease